Inactive Instrument

Calendar TapImmune Inc Nasdaq

Equities

US8760334081

Chart calendar TapImmune Inc

1eb3683.5oVJXeXzi_I2n8aL_XfpTjbgM4FmkFJZVdv87FY0aw0.hOciEYnCvJ562KD5iQSNLQPUergq-xkMZ7a2wSxYAUee3SEkr8Xkhkfclw~2cf776695ef575c23732cdcfaff4462b

Upcoming events on TapImmune Inc

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-12 Q4 2024 Earnings Release (Projected)

Past events on TapImmune Inc

2024-04-01 Hematologic Malignancies Global Summit
2024-03-26 10:00 H.C. Wainwright Cell Therapy Virtual Conference
2024-03-25 17:45 Q4 2023 Earnings Release
2024-01-09 Non Dilutive Funding Summit
2024-01-07 Biotech Showcase
2023-11-09 17:00 Q3 2023 Earnings Release
2023-09-13 08:30 H.C. Wainwright Global Investment Conference
2023-08-14 16:30 Q2 2023 Earnings Release
2023-06-06 09:00 Annual General Meeting
2023-03-22 08:10 Q4 2022 Earnings Release
2022-11-10 16:05 Q3 2022 Earnings Release
2022-09-15 09:20 Cantor Fitzgerald Cell & Gene Therapy Conference
2022-08-11 16:22 Interim 2022 Earnings Release
2022-05-24 09:00 Annual General Meeting
2022-05-13 07:00 Q1 2022 Earnings Release
2022-05-05 20:45 International Society for Cell & Gene Therapy Meeting - Abstract Number : 506
2022-05-05 20:45 International Society for Cell & Gene Therapy Meeting - Abstract Number : 936
2022-05-05 20:45 International Society for Cell & Gene Therapy Meeting - Abstract Number : 515
2022-05-05 20:45 International Society for Cell & Gene Therapy Meeting - Abstract Number : 937
2022-03-17 17:45 FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2024
Net sales
Million USD
Released
Forecast
Spread
0,21
0,00
-
0,47
0,48
-3.46%
1,24
0,00
-
9,01
9,00
0.15%

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-22,5
-23,2
2.92%
-28,9
-27,8
-3.86%
-39,5
-40,5
2.49%
0,00
0,00
-

-18,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-21,4
-22,2
3.26%
-28,7
-27,7
-3.56%
-41,9
-42,3
0.95%
0,00
0,00
-

-17,4

Net income
Million USD
Released
Forecast
Spread
-21,4
-22,2
3.26%
-28,7
-27,7
-3.56%
-41,9
-42,3
0.95%
0,00
0,00
-

-17,4

EPS
USD
Released
Forecast
Spread
-4,70
-4,86
3.29%
-6,10
-5,90
-3.39%
-5,50
-5,73
3.93%
-3,58
-3,60
0.56%

-1,28

Announcement Date12/03/2009/03/2117/03/2222/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
1,24
0,00
-
0,96
0,00
-
0,79
2,50
-68.38%
3,95
0,27
1381.07%
3,31
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-9,76
-10,8
9.21%
-9,79
-11,2
12.55%
-9,28
-8,72
-6.46%
-7,02
-11,3
37.7%




-2,45


-2,57


-5,29


-7,93

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,76
-10,8
9.38%
-9,91
-11,2
11.25%
-9,24
-8,74
-5.81%
-6,92
-10,9
36.23%




-2,26


-2,42


-5,17


-7,53

Net income
Million USD
Released
Forecast
Spread
-9,76
-10,8
9.38%
-9,91
-11,2
11.25%
-9,24
-8,74
-5.81%
-6,92
-10,9
36.23%




-2,26


-2,42


-5,17


-7,53

EPS
USD
Released
Forecast
Spread
-1,10
-1,28
13.73%
-1,20
-1,33
10%
-1,10
-1,05
-4.76%
-0,80
-1,30
38.46%
-3,27
-1,00
-227%

-0,25


-0,27


-0,37


-0,39

Announcement Date17/03/2213/05/2211/08/2210/11/2222/03/23----